Tests:CA 19-9: Difference between revisions

From Taranaki Lab Manual
Tests:CA 19-9
Jump to navigation Jump to search
No edit summary
No edit summary
Line 33: Line 33:
== Specimen Requirements ==
== Specimen Requirements ==
|-
|-
|Specimen Type
|Specimen  
|Serum
|Serum
Plasma
Plasma
|-
|Specimen Transportation
|
|-
|-
|Preferred
|Preferred
Line 49: Line 46:
|
|
|-
|-
|Pediatric Requirements
|Specimen Transportation
|
|-
|Paediatric Requirements
|0.5 <span style="background:#e30022"> Red </span> microtainer  
|0.5 <span style="background:#e30022"> Red </span> microtainer  
|-
|-
Line 55: Line 55:
== Aliquot Requirements ==
== Aliquot Requirements ==
|-
|-
|Sample Type
|Sample
|Serum
|Serum
|-
|-

Revision as of 13:17, 20 March 2025


Overview

Department Biochemistry 
Test Code C199
Synonyms C199

C19-9

19-9

Test Availability Tuesdays and Fridays

Contact the laboratory if testing required urgently. 

Turnaround Time 1 – 4 days 
Stability – Add test

Specimen Requirements

Specimen Serum

Plasma

Preferred 7mL Red-Top
Acceptable SST Yellow-Top
Unacceptable
Specimen Transportation
Paediatric Requirements 0.5 Red microtainer  

Aliquot Requirements

Sample Serum
Preferred Volume >500 uL
Minimum Volume 200 uL
Aliquot Transportation Samples should be separated from red cells within 24hrs of collection. 

Clinical Information

Reference Intervals <37 U/mL 
Test Method Abbott Architect analyser using Abbott reagents.  

CMIA method

Advanced Notice
Patient Preparation

Comments

Used for monitoring gastrointestinal malignancies 

For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.